Veterinary Medicines

PASTERBACT

Authorised
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
Download as PDF

Product identification

Medicine name:
PASTERBACT
Active substance:
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
Target species:
  • Sheep
  • Goat
  • Cattle (calf)
  • Sheep (lamb)
  • Goat (kid)
  • Cattle (cow)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
    20.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Cattle (cow)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Cattle (cow)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • LABORATORIOS HIPRA, S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2856 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."